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Abstract
Background: Increasing evidence suggests that the immune system has a beneficial role in the progression of
amyotrophic lateral sclerosis (ALS) although the mechanism remains unclear. Recently, we demonstrated that motor
neurons (MNs) of C57SOD1G93A mice with slow disease progression activate molecules classically involved in the
cross-talk with the immune system. This happens a lot less in 129SvSOD1G93A mice which, while expressing the
same amount of transgene, had faster disease progression and earlier axonal damage. The present study
investigated whether and how the immune response is involved in the preservation of motor axons in the mouse
model of familial ALS with a more benign disease course.
Methods: First, the extent of axonal damage, Schwann cell proliferation, and neuromuscular junction (NMJ)
denervation were compared between the two ALS mouse models at the disease onset. Then, we compared the
expression levels of different immune molecules, the morphology of myelin sheaths, and the presence of
blood-derived immune cell infiltrates in the sciatic nerve of the two SOD1G93A mouse strains using
immunohistochemical, immunoblot, quantitative reverse transcription PCR, and rotating-polarization Coherent
Anti-Stokes Raman Scattering techniques.
Results: Muscle denervation, axonal dysregulation, and myelin disruption together with reduced Schwann cell
proliferation are prominent in 129SvSOD1G93A compared to C57SOD1G93A mice at the disease onset, and this correlates
with a faster disease progression in the first strain. On the contrary, a striking increase of immune molecules such as
CCL2, MHCI, and C3 was seen in sciatic nerves of slow progressor C57SOD1G93A mice and this was accompanied by
heavy infiltration of CD8+ T lymphocytes and macrophages. These phenomena were not detectable in the peripheral
nervous system of fast-progressing mice.
Conclusions: These data show for the first time that damaged MNs in SOD1-related ALS actively recruit immune cells
in the peripheral nervous system to delay muscle denervation and prolong the lifespan. On the contrary, the lack of
this response has a negative impact on the disease course.
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Introduction
Amyotrophic lateral sclerosis (ALS) is the most common
neuromuscular disorder, affecting individuals from all
ethnic backgrounds, with an incidence of 2–3 cases per
100,000 population per year [1]. Terminal axonal degen-
eration with neuromuscular junction (NMJ) denervation
is an early component of motor neuron (MN) disease
in ALS [2]. In addition, it has now become clear that
ALS is a non-cell autonomous disease involving activa-
tion of microglia and astrocytes in the CNS [3] and in-
filtrates of peripheral T cells and macrophages in the
spinal cord and sciatic nerve [4, 5]. These non-neuronal
cells play an active role in MN death. In fact, selective
ablation of mutant SOD1 in astrocytes and microglial
cells and neonatal bone marrow (BM) transplantation
significantly increased MN survival and lifespan [3] of
mutant SOD1 transgenic mice. In contrast, T cell defi-
ciency accelerated the disease progression in these
mouse models [4, 6]. These studies have been mainly
focused on the CNS, while the contribution of immune
cells in the peripheral nervous system (PNS) has not
been fully analyzed.
ALS is a clinically heterogeneous disease with a high
variability in the rate of symptom progression even in
the familial cases [7, 8]. Growing evidence indicates that
also in mutant SOD1 mice, the most widely used model
of familial ALS, the severity of the disease is markedly
influenced by their genetic background [9–12]. In fact,
we have recently obtained and characterized two mouse
strains (C57BL6 and 129Sv) carrying the same copy
number of the human SOD1G93A transgene that showed
remarked difference in the speed of symptom progres-
sion [13, 14]. In particular, the fast-progressing mice
(129SvSOD1G93A) compared to the slow progressors
(C57SOD1G93A) showed an earlier impairment of motor
function and shorten survival, which was unrelated to
the extent of MN loss in the lumbar spinal cord, des-
pite significant differences in their MN transcriptome
[9, 13, 14]. Noteworthy is the fact that rapidly progres-
sing mice, unlike the slow progressor, showed markedly
decreased expression of transcripts linked to axonal
transport and neuronal projection [9, 14] at disease on-
set, suggesting major involvement of the axonal com-
partment both at the central and peripheral levels to
determine the different mice phenotypes. This was then
demonstrated by the ex vivo diffusion tensor imaging
and histopathological analysis showing an earlier axonal
degeneration in the white matter of the spinal cord of
fast- compared to the slow-progressor mice [15]. In
contrast, MNs of slow- but not fast-progressing mice
specifically activated and translocated to the peripheral
motor axons immune molecules (i.e., major histocom-
patibility complex I (MHCI)) directly involved in the
induction of an adaptive immune response [9, 14].
In the present study, we further extended these obser-
vations analyzing in more details the involvement of the
PNS and the associated immune system in the modula-
tion of disease progression. We clearly demonstrated
that the dysregulation of PNS is the origin of the differ-
ence between the two transgenic mice strains and that
immune cell infiltration in this compartment is essential
to delay muscle denervation of SOD1G93A mice.
Methods
Mice
Female transgenic SOD1G93A mice on C57BL/6JOlaHsd
or 129SvHsd genetic background, hereafter indicated as
C57SOD1G93A and 129SvSOD1G93A, respectively, and
corresponding non-transgenic (Ntg) littermates were
used. Procedures involving animals and their care were
conducted in conformity with institutional guidelines
that comply with national (Legislative Degree 26, March,
2014) and international (EEC Council Directive 2010/63,
August, 2013) laws and policies.
Animals studies were approved by the Mario Negri
Institute Animal Care and Use Committee and by the
Italian Ministerial decree no. 84-2013.
Laser-captured microdissection and microarray data
analysis
We extrapolated data for β2m, Tap1, H2_K-D, and Lmp7
messenger RNA (mRNA) levels in C57-Ntg; 129Sv-Ntg,
and C57-SOD1G93A laser-captured MNs from micro-
array analysis; the detailed procedure has been previ-
ously described in Nardo et al. [14]. Additional
information is supplied in the Additional file 1.
Immunohistochemistry
The spinal cord and sciatic nerve were processed as pre-
viously described [8]. Briefly, the mice were perfused
with Tyrode’s buffer, followed by Lana’s fixative (4 % for-
malin and 0.4 % picric acid in 0.16 M PBS, pH 7.2) at
20 °C. The lumbar spinal cord and sciatic nerves were
quickly dissected out. The tissue was left in the same
fixative for 90–180 min or overnight at 4 °C, rinsed, and
stored 24 h in 10 % sucrose with 0.1 % sodium azide in
0.01 M PSB at 4 °C for cryoprotection, before mounting
in optimal cutting temperature compound (OCT). The
spinal cords and sciatic nerves were cut, respectively, in
30- and 14-μm sections. The following primary anti-
bodies and staining were used: rat anti-MHC class I ER-
HR 52 clone (1:100; Abcam), rat anti-CCL2 (1:50;
Abcam), rabbit anti-β2m (1:500; Proteintech), rabbit
anti-Lmp7 (1:500; AbD Serotec), mouse anti-SMI-31
(1:1000; Sternberger Inc), rabbit anti-CD8 (1:50; Abcam),
rabbit anti S100β (1:400; Sigma-Aldrich), α-btx (5 μg/
ml) conjugated with Alexa-594 (Invitrogen), and Neuro-
Trace conjugated with Alexa-488 or Alexa-594 (1:500;
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Invitrogen). Secondary antibodies were as follows: Alexa
488 or Alexa 594 goat anti-rat, Alexa 488 or Alexa 594 goat
anti-rabbit, and Alexa 594 goat anti-mouse (Invitrogen). All
immunohistochemistry followed an indirect immunostain-
ing protocol whereas peroxidase-diaminobenzidine (DAB)
reaction was used for detecting MHCI in the spinal cord
and DAB (brown) plus DAB-NICHEL (blue) reactions in
the sciatic nerve for the double labeling of MHCI (1:00)
and CD8 (1:50).
Immunohistochemical evaluation of Lmp7 in human
obturator nerve
All procedures in studies involving human participants
were in accordance with the ethical standards of the in-
stitutional and/or national research committee and with
the 1964 declaration of Helsinki and amendments, or
comparable ethical standards. We studied a motor nerve
sample from a sporadic ALS male patient, whose anter-
ior branch of the obturator nerve had been previously
biopsied for diagnostic purposes, as described [16]. This
patient developed progressive lower-limb weakness at
the age of 52; motor nerve biopsy led to a neuropatho-
logical diagnosis of motor neuron disease. Subsequently,
he developed upper motor neuron signs, allowing a
clinical diagnosis of definite ALS [17]. A normal nerve
sample belonging to a 65-year-old patient with a final
diagnosis of distal sensorimotor peripheral neuropathy
was studied as a control. Although the histopatho-
logical analysis showed a normal nerve at time of bi-
opsy, clinical worsening and neurophysiological follow-up
subsequently allowed a final diagnosis of peripheral neur-
opathy. Neuropathological diagnosis was based on previ-
ous diagnostic criteria [18]. Transverse 10-μm sections of
the frozen nerve were cut with a cryostat and trans-
ferred to 0.1 % poly-D-lysine-coated glass slides. The
cryosections were immunostained with affinity-purified
fluorescein isothiocyanate (FITC)-conjugated goat anti-
bodies to human LMP7 (1:100; Southern Biotechnology
Assoc.) and tetramethylrhodamine (TRITC) conjugated
goat antibodies (Southern Biotechnology Assoc.) to hu-
man neurofilament 200 kDa (rabbit) (1:1000; Chemicon).
Coherent Anti-Stokes Raman Scattering (CARS) analysis of
the sciatic nerves
The animals were sacrificed with cervical dislocation, and
their sciatic nerves were rapidly surgically explanted and
frozen in dry ice in a WillCo dish (GWSt-3522; WillCo
Wells, Amsterdam, The Netherlands). The samples were
then thawed by immersion into warm (~38 °C) Dulbecco’s
phosphate buffer saline (D8537; Sigma-Aldrich, Saint Luis,
Missouri, U.S.A.) and immobilized with a custom-made
electrophysiology-type anchor. The explanted sciatic
nerves from C57SOD1G93A, 129SvSOD1G93A, and relative
NTG mice were observed with an RP-CARS microscope
[19] tuned to CH2 molecular vibrations yielding the aver-
age in-plane orientation anisotropy (α) of the chosen mo-
lecular vibrations and their average orientation (φ) within
the sub-micrometric excitation volume [20]. The acquired
z-stacks were analyzed with a custom-made Python soft-
ware (Python Software Foundation, Beaverton, OR, USA)
to threshold the myelin walls and to extract the stack dis-
tribution of the α values (we employed the same algorithm
described in [21], but computed the threshold on the α
value images). The α value distributions are shown in
Additional file 1: Figure S1. Finally, the same z-stacks were
analyzed with a second custom-made Python software
to extract the stack-based average dispersion (β value)
of the myelin-associated φ values over a chosen spatial
scale (see Additional file 1). The β value is an indicator
of the average micrometric longitudinal straightness of
the myelin sheaths.
Muscle denervation
Tibialis anterior muscles were dissected out and snap-
frozen in isopentane cooled in liquid nitrogen. Twenty-
micrometer serial longitudinal cryosections were collected
on poly-lysine objective slides (VWR International). The
sections were stained with anti-synaptophysin (SYP)
(1:100; Synaptic System) as pre-synaptic marker. The sec-
ondary antibody was FITC-labeled goat anti-rabbit (1:500,
Invitrogen). Subsequently, the sections were stained with
α-bungarotoxin (α-BTX) coupled to Alexa Fluor 594
(1:1200; Invitrogen) as post synaptic marker. Fluorescence
images along the z-axis were taken by Olympus confocal
microscopy using a ×20 objective, and z-stacking was
done using Fiji software (with Z-Stack Projection/SUM
command) (ImageJ, US National Institutes of Health,
Bethesda, MD, USA). End plates were scored as inner-
vated if there was complete overlap between SYP and a-
BTX staining and scored as denervated if they showed
only α-bungarotoxin staining.
Western blot
The mice were decapitated, and the spinal cord and sciatic
nerve were rapidly dissected. The spinal cord was proc-
essed as previously described [14]. The sciatic nerves and
muscles were powdered in liquid nitrogen then homoge-
nized by sonication in ice-cold homogenization buffer
centrifuged at 13,000 rpm for 15 min at 4 °C, and the su-
pernatants were collected and stored at −80 °C. Equal
amounts of total protein homogenates were loaded on
polyacrylamide gels and electroblotted onto PVDF mem-
brane (Millipore) as previously described [14]. Densito-
metric analysis was performed with Progenesis PG240
v2006 software (Nonlinear Dynamics). Immunoreactivity
(IR) was normalized to β-tubulin, β-actin, or the total
amount of protein detected by red Ponceau (Sigma-
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Aldrich) or SYPRO Ruby Blot (Thermo Fisher scientific).
Additional information is supplied in the Additional file 1.
Quantitative reverse transcription PCR
The spinal cords, sciatic nerves, and muscles were per-
fused in 0.1 M PBS, freshly collected and then frozen on
dry ice. The total RNA from spinal cord was extracted
using the Trizol method (Invitrogen) and purified with
PureLink RNA columns (Life Technologies). For fibrous
tissues (sciatic nerve and muscles), the RNeasy® Mini Kit
(Qiagen) was used. The RNA samples were treated with
DNase I, and reverse transcription was done with a High
Capacity cDNA Reverse Transcription Kit (Life Tech-
nologies). For quantitative reverse transcription PCR
(RT-qPCR), we used the TaqMan Gene expression assay
(Applied Biosystems) following the manufacturer’s in-
structions, on complementary DNA (cDNA) specimens
in triplicate, using 1X Universal PCR master mix (Life
technologies) and 1X mix containing specific receptor
probes. The levels of transcripts were normalized to β-
actin. The mean values of the triplicate results for
each animal were used as individual data for 2−ΔΔCt
statistical analysis. Additional information is supplied
in the Additional file 1.
Statistical analysis
The Mann-Whitney test was used to compare differ-
ences between two groups and one-way or two-way
ANOVA was used to compare differences between more
than two groups. For the CARS analysis, z-stack-based
indicators (i.e., the α values and the β values) were statis-
tically analyzed with a general linear mixed model imple-
mented in R (R Foundation, Vienna, Austria), using the
strain (C57 vs. 129Sv) and the mutation (Ntg vs. G93A)
as fixed factors and the nerve as a random factor. Post
hoc comparisons between the experimental groups were
instead performed with Mann-Whitney test on the
specimen-based medians.
Results
The severity of disease in SOD1G93A mice correlates with
earlier muscle denervation
The present study indicates that muscle innervation at
the disease onset is more severely perturbed in
129SvSOD1G93A than in C57SOD1G93A mice confirming
the prediction of a faster disease progression in the
former mice as compared to the second ones slow pro-
gressor. Denervation of the tibialis anterior (TA) muscle
was more extensive in the former mice, with only 37 ±
1.5 % of occupied end plates compared to 65 ± 5 % in
the C57SOD1G93A mice (Fig. 1a, b). In addition, the
transcript levels of the gamma subunit of the cholinergic
nicotinic receptor (AChR-γ), the expression of which is
abundant in the presence of denervated or defective
NMJs [22], showed significantly greater upregulation in
the TA muscles of the fast-progressing mice compared
to the slow progressors (Fig. 1c).
Axonal dysregulation and reduced Schwann cell
proliferation are prominent in fast-progressing mice at
disease onset
The sciatic nerves of the fast-progressing mice showed a
marked downregulation of neurofilaments (Fig. 2a, b)
and acetylated tubulin (Fig. 2a, c) and upregulation of β-
importin (Fig. 2a, d), three reliable indices of axonal
stress and degeneration [23–25]. This effect was not
seen in the slow-progressing mice at the same disease
stage. In addition, there were differences in Schwann
cells (SCs) between the two ALS mouse strains. In fact,
levels of glial fibrillary acidic protein (GFAP) (Fig. 2a, e)
Fig. 1 Muscle innervation is more impaired in fast- (129SvSOD1G93A) than in slow-progressing C57SOD1G93A mice. a, b Denervation was analyzed
in tibialis anterior muscle of 129SvSOD1G93A and C57OD1G93A strains and Ntg littermates. a α-Bungarotoxin (BTX, red) was used to identify the
postsynaptic domain; synaptophysin (SYP, green) was used to identify pre-synaptic terminals (scale bar, 50 μm). b Mean ± SEM (n = 3 mice; ~100
bungarotoxin-positive endplates per animal were randomly chosen and analyzed). ***P value <0.001 (C57G93A vs 129SvG93A); °°P value <0.01
(129SvNtg and C57Ntg vs C57G93A); ####P value <0.0001 (129SvNtg and C57Ntg vs 129SvG93A) by two-way ANOVA with Tukey’s post-analysis.
c Real-time PCR for AChR-γ transcript in the TA muscles of C57SOD1G93A and 129SvSOD1G93A mice compared with the Ntg littermates. Data are
normalized to β-actin and expressed as the mean (±SEM)-fold change ratio between the C57SOD1G93A mice, 129SvSOD1G93A mice, and controls
(n = 4 per group). ****P value <0.0001 (C57G93A vs 129SvG93A); °°°°P value <0.0001 (129SvG93A vs NtgC57 and Ntg129Sv); by two-way ANOVA
with Tukey’s post-analysis
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and phospho (P)-ERK (Fig. 2a, f ), which are known to
induce de-differentiation and proliferation of the SCs
during axonal regeneration [26, 27], were higher in the
slow-progressing mice than in those with fast disease
progression. Such differences reflect the different basal
levels of the proteins in the two non-transgenic strains,
being higher in C57Ntg than 129SvNtg mice. This is also
evident when the two mouse strains were analyzed at
the same age (98 days) (Additional file 1: Figure S2a–c).
Thus, even though both SOD1G93A mouse strains can
activate SC de-differentiation and proliferation in the
sciatic nerves, in terms of absolute levels, this appears
more pronounced in mice with a slow disease course
compared to the fast progressors.
Based on these results, RP-CARS microscope analysis
was exploited to detect the myelin-associated α values in
the sciatic nerve of slow- and fast-progressing mice. α
value is an indicator of the myelin molecular order,
and it is tightly associated with the myelin health sta-
tus [19, 20, 28]. Representative RP-CARS images of
sciatic nerve longitudinal optical sections are shown in
Fig. 3: a large-scale traditional-CARS image (Fig. 3a)
and two images obtained by color-mapping the α
(Fig. 3b) and the φ (Fig. 3c) values are represented.
The statistical analysis performed on the explanted sci-
atic nerves from ten C57 mice (five Ntg; five
SOD1G93A) and eight 129Sv mice (3 Ntg; 5 SOD1G93A),
revealed that the 129Sv strain is associated with a de-
crease of 1.9 with respect to the C57 strain in the α
value (P < 0.05), and the presence of the G93A muta-
tion is associated with a decrease of 2.0 with respect to
the Ntg (P < 0.05) in the same indicator. Box plot
depicting the α values in the different conditions is
shown in Fig. 3d. The same microscopic acquisitions
were also used for the analysis of the average disper-
sion of the myelin-associated φ values. This indicator,
called β value, reflects the longitudinal straightness of
the myelin sheaths over a chosen spatial scale (see
Additional file 1). The statistical analysis of the results
highlighted a significant decrease (P < 0.001) in the β
value for the 129Sv compared to the C57 strain at a
spatial scale of 5 μm (Fig. 3e). We noted that factor-of-
100 changes (from 0.5 to 45 μm) in the spatial scale do
not significantly alter the results implying that the
Fig. 2 Sciatic nerve dysregulation of 129SvSOD1G93A mice at disease onset. a Representative western blots images of neurofilaments, acetylated
tubulin, GFAP, P-ERK, and β-importin, and tubulin on sciatic nerve extracts from the C57SOD1G93A, 129SvSOD1G93A, and Ntg littermates at the
onset of the disease. b–f Densitometric analysis shows reductions in the expression of b neurofilaments and c acetyl tubulin as well as specific
activation of d β-importin in the sciatic nerve of the 129SvSOD1G93A mice. In addition, activation of e GFAP and f P-ERK was reduced in the sciatic
nerve of the 129SvNtg and 129SvSOD1G93A mice. P-ERK levels were normalized to relative levels of ERK (not shown). Mean ± SEM (n = 4 per
group). **P value <0.01; ***P value <0.001; ****P value <0.0001 (C57G93A vs 129SvG93A in b–f); °°P value <0.001; (NtgC57 vs Ntg129Sv in e and f);
#P value <0.05 (129SvG93A vs NtgC57 in e); $$$$P value <0.0001 (C57G93A vs NtgC57 and Ntg129Sv in e); §P value <0.05; §§§§P value <0.0001
(129SvG93A vs NtgC57 and Ntg129Sv in e); (129SvG93A vs Ntg129Sv in f) by two-way ANOVA with Tukey’s post-analysis
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differences occur over a broad range of spatial scales.
It should be pointed out, however, that the observed
C57 mice were 1 month older than the 129Sv mice and
that the resultant length value is known to correlate
with age in wild-type mice. Nonetheless, the difference
(around 0.1) observed here between mice of different
strains (slow- and fast-progressing mice, 98 vs.
135 days) is about 30 times larger than the levels previ-
ously observed for 5-month-older mice belonging to
the same strain (28 vs. 140 days) [29]. In addition, post
hoc analysis between experimental groups revealed
that the difference in the β value between the C57 and
the 129Sv strains is significant in the SOD1G93A mice
(P < 0.01) and not significant in the Ntg case (P ≈ 0.13).
Sustained activation of the MHCI pathway, centrally and
peripherally, occurs in slow- but not fast-progressing
mice
We have previously demonstrated that MHCI is acti-
vated more in MNs of slow-progressing than fast-
progressing mice at disease onset [14]. The present
study extended the analysis to other components for
MHCI presentation such as Lmp7, H2_D-K, Tap1, and
β2m. Basal mRNA levels of H2_D-K and β2m were sig-
nificantly higher in the C57Ntg than 129SvNtg MNs,
with fold changes, respectively, of 3.6 and 4.7 times
(Additional file 1: Figure S3a). When we measured the
mRNA expression of Lmp7, H2_D-K, Tap1, and β2m ob-
tained by microarray analysis of laser-captured MNs
from the C57SOD1G93A mice (n = 4) compared to the
Ntg littermates (n = 4) at the presymptomatic (56 days),
symptom onset (135 days), and symptomatic (147 days)
stages of the disease, all four genes showed similar pat-
terns of expression during disease progression, with a
peak at disease onset and a progressive decrease at the
symptomatic stage (Additional file 1: Figure S3b). No
differences were found for the 129Sv mice [14]. For this
reason, we examined the expression and distribution of
the components of this pathway in more detail in the
CNS and PNS of the C57SOD1G93A mice.
Under basal conditions, the levels of MHCI were very
low in the lumbar spinal cord MN perikarya (Additional
file 1: Figure S3c), while the protein was highly
expressed in microglia and oligodendrocytes sur-
rounding MNs [14] (Additional file 1: Figure S3d) and
in efferent motor axons (Additional file 1: Figure S3e).
β2M and LMP7 were upregulated and colocalized
within a sub-population of MN perikarya in the
C57SOD1G93A mice but not in the control littermates
(n = 5) (Additional file 1: Figure S3f–h). However, like
the MHCI, both LMP7 and β2M were more expressed
in the sciatic nerve of the C57SOD1G93A than the Ntg
mice (Fig. 4a, b; Additional file 1: Figure S4a, b) and
colocalized in motor axons with SMI-31, a specific
axonal marker (Fig. 4c–e; Additional file 1: Figure
S4c–e). LMP7 and MHCI intensely colocalized in
swollen and vacuolated regions of the axons reminis-
cent of Wallerian axonal degeneration (Fig. 4f–i). High
levels of LMP7 were also observed in obturator nerve
biopsies from a sporadic ALS patient (Fig. 4j–r),
Fig. 3 Myelin is more disorganized in sciatic nerves of 129Sv-SOD1G93A at disease onset. a Large-scale CARS image of a longitudinal optical
section of a 129Sv-SOD1G93A mouse sciatic nerve. Myelin debris reminiscent of Wallerian axonal degeneration are indicated by a blue arrow.
b Magnification of the blue square area in the panel a representative of anisotropy RP-CARS image highlighting the α value mapped onto the
hue according to the color bar. c Bond-orientation RP-CARS image of the same area depicted in b mapping the φ value onto the hue. The
saturation and the value of the images in a and b were constructed as previously described [15]. Scale bar, 10 μm. On average, 2.9 z-stacks,
each composed of 10–11 slices (200 × 200 pixels per slice, corresponding to an area of 50 μm× 50 μm on the sample) were acquired for each
nerve, and when possible, the sampling was performed at the proximal, the central, and the distal sections of the nerve. For all the mice
except one, we observed both sciatic nerves. d, e Box plots showing the α value (d) and the β value (e) in the different conditions. *P value <0.05;
***P value <0.001 by general linear mixed model
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Fig. 4 LMP7 is activated in the peripheral nerve axons of C57SOD1G93A mice and ALS patients. a, b LMP7 immunoreactivity (green) is strikingly
upregulated in the sciatic nerve of the C57SOD1G93A mice at the disease onset (G93A) compared to the Ntg littermates (NTG); scale bar,
100 μm. c–e Representative co-localization of LMP7 with SMI-31 (axonal marker; red) in the sciatic nerve of C57SOD1G93A mice; scale bar,
20 μm. f–i MHCI (green), LMP7 (red), and SMI-31 (blue) co-localization in the sciatic nerve of C57SOD1G93A mice, highlighting MHCI-LMP7
co-immunoreactivity in motor axons with vacuoles typical of Wallerian degeneration. j–n Transverse section of an obturator nerve biopsy from
a sporadic ALS patient (ALSP) and control (CTRL), showing a marked LMP7 activation (green) in ALS patient; DAPI: blue; scale bar, 50 μm; scale
bar, 150 μm. o–r Longitudinal section of the obturator nerve biopsy from an ALS patient, showing LMP7 (green) co-localization with neurofilaments
(red); scale bar: 50 μm; s–v LMP7 is expressed by terminal motor axons but not at the NMJ of C57SOD1G93A mice; LMP7 (green), α-BTX (red), and MHCI
(blue); scale bar, 50 μm
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suggesting that activation of this pathway is not con-
fined to SOD1-related ALS. MHCI [14] and β2M, but
not LMP7, were also highly expressed at NMJs in
C57SOD1G93A mice (Fig. 4s, v; Additional file 1: Figure
S4f ). In addition to motor axons, MHCI was more
expressed in SCs of C57SOD1G93A mice than 129SvG93A
mice (Fig. 5a–c). Since MHCI presentation is critical for
adaptive immunity, we examined CD8+ T cell infiltration
in the spinal cord and sciatic nerves of ALS mice. The
transcript for the CD8+ T cell receptor was highly overex-
pressed in the spinal cords of the C57SOD1G93A mice at
disease onset and the symptomatic stage (Fig. 5d) mimick-
ing the pattern of expression of MhcI and Lmp7 mRNAs
in laser-captured MNs (Additional file 1: Figure S3b). In
contrast, there was no significant change in CD8+ T
cell receptors within the spinal cords of 129SvG93A
mice compared to the Ntg129Sv mice at disease onset
(Additional file 1: Figure S5). CD8 mRNA levels were
also higher in the sciatic nerve of C57SOD1G93A mice
than the Ntg littermates at disease onset (Fig. 5e). This
was further confirmed by immunohistochemistry,
showing CD8+ T lymphocyte infiltration in the sciatic
nerves of the C57SOD1G93A mice (Fig. 5f ), forming
clusters close to degenerating motor axons expressing
high levels of MHCI (Fig. 5g, h). In contrast, CD8
mRNA was downregulated in the sciatic nerve of the
129SvSOD1G93A mice at disease onset compared to the
Ntg littermates (Fig. 5e).
Peripheral activation of CCL2 and complement subunit C3
is responsible for greater macrophage recruitment in the
sciatic nerve of slow-progressing mice
Besides MHCI, we previously showed that CCL2 and C3
are specifically upregulated by MNs in slow-progressing
mice at disease onset [14]. In this study, there was differ-
ential expression of the two proteins in the peripheral
nerves of the two mouse strains as well. The levels of
CCL2 were upregulated in the sciatic nerve of
C57SOD1G93A mice whereas they were almost absent in
129SvSOD1G93A mice (Fig. 6a–f ). Increased CCL2 im-
munostaining colocalized with SMI31 in motor axons
(Fig. 6c) and with S100β in SCs (Fig. 6d) of slow-
progressing mice. Since CCL2 is a monocyte/macro-
phage chemoattractant protein, we measured the levels
and the distribution of the macrophage-specific protein
Iba1 in the sciatic nerves of the two mouse strains. Im-
munoblot and immunohistochemistry both showed
higher levels of Iba1 in the sciatic nerves of the
C57SOD1G93A than in the 129SvSOD1G93A mice at dis-
ease onset (Fig. 6e, g, h). Iba1 was expressed not only
by macrophages (Fig. 6i–k) but also by SCs (Fig. 6i, j;
Additional file 1: Figure S5a) in the sciatic nerve of the
C57SOD1G93A mice. The levels of complement C3 were
also significantly raised in the sciatic nerve of the
C57SOD1G93A but not 129SvSOD1G93A mice (Fig. 6e, f ).
The activation of the complement is also responsible
for the recruitment of blood macrophages in SOD1G93A
mice [5]. Despite such marked recruitment of macro-
phages, the RT-qPCR on the sciatic nerve extracts
showed no difference in the expression levels of pro-
inflammatory factors such as TNFα, IL6, and Ly6c;
however, the M2-myeloid marker Ym1 was higher in
the C57SOD1G93A mice than the Ntg mice (Additional
file 1: Figure S6b–e).
Discussion
This study demonstrates that the integrity of PNS plays
an essential role in governing the onset of the disease
and the speed of its progression in two mouse models of
familial ALS carrying the same amount of human
SOD1G93A transgene on a different genetic background
and suggests that this phenomenon is influenced by the
immune system. In fact, while both mouse ALS strains
present similar loss of MNs during the disease course
[13], the rapid-progressor 129SvSOD1G93A mice present
earlier axonal impairment and denervation of hind limb
muscles as indicated by the marked upregulation of the
AChRγ-subunit mRNA levels in the TA muscles com-
pared to the C57SOD1G93A mice. Normally, the AChRγ-
subunit it is almost undetectable or at very low levels in
innervated, normally active muscle, while it becomes
abundant along the whole fiber length in denervated
muscle or in muscle in which the neuromuscular contact
is intact but the release of transmitter is blocked [22].
This is in line with the hypothesis that alterations at the
NMJ might precede the massive MN loss [2]. Muscle de-
nervation is associated with a with marked disruption of
motor axons in 129SvSOD1G93A mice demonstrated by
the reduced levels of acetylated tubulin and neurofila-
ments, two indices of axonal transport and structure
[24, 25] and by the increase of β-importin, a marker of
axonal stress [23] in their sciatic nerve.
The extent of the de-differentiation and proliferation
of SCs during regeneration of the damaged motor axons
in SOD1G93A mice also seems to play a relevant role
modulation the disease course in these ALS mouse
models. In fact, the basal expression in sciatic nerves of
P-ERK, which is fundamental to stimulate SCs de-
differentiation during reinnervation [26], is much lower
in the 129Sv NTg than in the C57 NTg mice. This differ-
ence was reflected in a reduced level of activation in
129SvSOD1G93A mice in comparison to C57SOD1G93A
mice. The same difference is evident for the expression
of GFAP in the sciatic nerves, which is essential to pro-
mote the proliferation of SCs after damage [27, 30]. In
fact, depletion of this protein in the sciatic nerves has
been reported to delay nerve regeneration after axotomy
in mice [27]. RP-CARS structural analysis of the
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explanted sciatic nerves further supports this concept at
morphological level showing significant differences in
myelin anisotropy between the C57 and 129sv back-
ground. Statistically significant differences were also
found in the β value between the two strains (and, in
particular, between SOD1G93A mice) highlighting the
contribution of mouse genetic background in promoting
the integrity of the myelin structural architecture during
disease progression.
This result is in accordance with the studies by Bieber
et al. [31] who, by using different inbred mouse strains
model of chronic progressive multiple sclerosis, clearly
demonstrated that the axonal integrity and neurologic
function is mainly affected by genetic background-
related loci inherited as dominant traits. In parallel, the
study of different experimental mouse models of axon
remyelination has allowed identification of potential
genetic factors able to enhance axonal remyelination
[32]. For instance, fibroblast growth factor 2 (FGF2)
and platelet-derived growth factor (PDGF) promote the
proliferation of oligodendrocyte precursor cells (OPCs)
[33, 34], while insulin growth factor 1 (IGF1) stimulates
both OPCs differentiation and axon myelination [35].
In addition, P-ERK, which we observed to be more
expressed in the C57 than the 129Sv mice, is essential
to coordinate the stress response of myelinating oligo-
dendrocytes following insult [36].
The mouse genetic background also profoundly influ-
ences the immune system response. In fact, inflamma-
tory cell recruitment is markedly lower in the 129Sv
than in the C57 mice following thioglycolate intraperito-
neal injection [37]. This is consistent with our observa-
tion of a reduced macrophage and T cell infiltration in
the peripheral nerves of the 129SvSOD1G93A compared
to C57SOD1G93A mice. The striking activation of the
immunoproteasome and MHCI in motor axons and SCs
of C57SOD1G93A mice correlates with the specific infil-
tration of CD8+ T cells in sciatic nerves. The recruit-
ment of macrophages is related to the coordinated and
specific activation of both CCL2 and the complement
C3 subunit. Apparently, this reactive immune response
is not accompanied by inflammation as no significant
upregulation of pro-inflammatory factors (TNFα; IL-6;
Ly6c) were observed in the sciatic nerves of the
C57SOD1G93A mice. By contrast, an increase in the M2
marker, Ym1, suggested a shift towards a protective
macrophage phenotype. Thus, these findings indicate a
beneficial role of immune cell infiltrates during the dis-
ease progression of SOD1-related ALS mice.
Several observations suggest the importance of im-
mune infiltration in CNS repair [38–42]. For instance,
recent studies demonstrated a beneficial role of
macrophage infiltration in mouse models of experi-
mental autoimmune encephalitis (EAE). In this regard,
the transfer of M2-polarized monocytes resulted in a
suppression of EAE [43, 44]. Additional studies in
EAE mouse models and other disorders indicate that
T cells responses can facilitate CNS repair at a later
stage by restricting a prominent secondary wave of
damage [45–48].
Based on these and our findings, we hypothesize that
in the PNS of slow-progressing SOD1 mutant mice the
SCs together with CD8+ T cells and peripheral macro-
phages cooperate in the targeted destruction of defective
motor fibers expressing axon growth inhibitors (e.g.,
myelin debris). This would then promote the de-
differentiation and proliferation of SCs to create a
growth-permissive milieu for new neurites generated fol-
lowing axonal injury [49–51] (Fig. 7a, b).
This scenario resembles that previously reported in
experimental mouse models of axon remyelination in
which the proliferation and differentiation of oligo-
dendrocytes precursor cells were accompanied by im-
mune cells infiltration [52–54]. Notably, the depletion
or pharmacological inhibition of macrophages follow-
ing toxin- or virus-induced demyelination leads to an
impairment of remyelination [55–57], as does an ab-
sence of T cells [58, 59]. This evidence suggests that
protective autoimmunity is a physiologically evoked
mechanism through which the body harnesses the im-
mune system in order to protect itself against neur-
onal degeneration.
This mechanism is more prominent in the PNS where
immune cell infiltration is not restricted, in contrast to
(See figure on previous page.)
Fig. 5 The greater expression of MHCI in the sciatic nerve of C57SOD1G93A mice leads to an increase in CD8+ T cell infiltration. a–c Confocal
micrographs of longitudinal section of the sciatic nerve of the a C57SOD1G93A and b 129SvOD1G93A mice showing greater activation of MHCI
(green) and c its co-localization with SCs (red) in the peripheral nerve of the less severe phenotype. CD8+ T cells specifically infiltrate the spinal
cord, sciatic nerve, and hind limb muscles of C57SOD1G93A mice at disease onset. d Longitudinal real-time PCR for CD8 co-receptor transcript in
the lumbar spinal cord of C57SOD1G93A mice compared to Ntg littermates. Data are normalized to β-actin and expressed as the mean (±SEM)-fold
change ratio between n = 5 C57SOD1G93A and controls. **P value <0.01 by one-way ANOVA with Tukey’s post-analysis. e Real-time PCR for CD8
co-receptor transcript in the sciatic nerve of C57SOD1G93A and 129SvSOD1G93A mice compared to respective Ntg littermates at the symptom
onset. Data are normalized to β-actin and expressed as the mean (±SEM)-fold change ratio between n = 5 C57SOD1G93A, n = 4 129SvSOD1G93A,
and relative controls at disease onset. *P value <0.05; **P value <0.01 by Mann and Whitney test. f CD8+ T cells infiltrate the sciatic nerve of
C57SDO1G93A mice in close proximity to degenerating motor axons expressing high levels of MHCI; (blue, CD8+ cells indicated by red arrows;
brown, MHCI); (scale bar, 50 μm). g, h High magnification highlights CD8+ cell clusters wrapping MHCI+ motor axons (scale bar 20 μm)
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the CNS [38]. Barrette et al. recently demonstrated that
peripheral macrophages were essential to promote the
production of neurotrophins (NT-3; BDNF) in regener-
ating motor axons and macrophage depletion signifi-
cantly slowed axon regeneration and functional recovery
after sciatic nerve injury [60]. Moreover, the CCL2-
mediated neuron-macrophage interaction is vital for
amplification and maintenance of enhanced regenerative
capacity by preconditioning peripheral nerve injury [61].
In vivo imaging in a SOD1G93A mice revealed distinct in-
flammatory activity of CNS microglia compared to PNS
macrophages, the latter showing no substantial morpho-
logical reaction during degeneration of peripheral motor
axons, but a passive role in clearing debris, particularly
lipid-rich myelin [62]. In keeping with this, myelin inges-
tion by myeloid cells in vitro induces a foamy appear-
ance and confers an anti-inflammatory function [63].
This evidence indicates about an essential role of
hematogenous macrophages in promoting the remyeli-
nation of defective motor fibers. In addition, CD8+ T
cells infiltrating the peripheral nerves may be essential
not only to promote the phagocytosis of myelin debris
but also for limiting the activity of effector T cells and
macrophages once the remyelination is completed (re-
covery phase) [49]. In fact, it is well known that the
CD8+ T cells include a subset of regulatory T cells
(CD8+ Tregs) expressing specific regulatory markers
such as CD103, FoxP3, or CD122 [64]. These were the
first described subset of T cells capable of inducing im-
mune suppression in vitro [65] and showing a greater
immunosuppressive effect than CD4+ Tregs in a num-
ber of models including EAE [66, 67].
Conclusions
It is generally accepted that terminal axonal degener-
ation and NMJ denervation occur before the loss of
MNs in ALS [2]. However, this evidence was largely
neglected for years with the result that no preclinical tri-
als designed to inhibit degeneration of MN cell bodies in
SOD1G93A mice yielded the expected outcomes in terms
of therapeutic benefit. There is growing evidence now
that even complete rescue of MN somata may not be
enough to counteract the disease progression in SOD1-
G93Amice [68]. This agrees with our findings which high-
light that the extent of axonal and neuromuscular
dysfunction, rather than MNs loss, seems predictive of
a more aggressive phenotype. The level of degeneration
(or preservation) of this compartment may therefore
underlie the heterogeneity of ALS, which is a powerful
confounding factor in evaluating the real efficacy of
treatments [7].
Our results demonstrate that genetic background in-
fluences the basal levels of proteins that are essential
to better preserve the myelination of peripheral motor
axons during disease progression. In addition, we
found that the maintenance of PNS function through
the interaction with a specific immune response is es-
sential for delaying disease progression in transgenic
mouse models suggesting that genetic differences in
immune responsiveness could affect the outcome of
ALS. Accordingly, it will be extremely relevant to con-
duct genetic linkage analysis on F1 backcross gener-
ation between fast and slow mouse strains to search
for genetic loci linked to enhanced remyelination and
immune activation.
With respect to the translation of these findings to
human ALS, so far there are no studies comparing
the PNS of fast- and slow-progressing ALS patients
due to the limited availability of tissues. However,
here we demonstrate for the first time that one of
the main components of the MHCI pathway, the
LMP7, is upregulated in the motor axon of a spor-
adic ALS patient indicating that this phenomenon is
not strictly related to the overexpression of mutant
SOD1. We have not been able to investigate whether
this variation correlates with a protective or detri-
mental effect on motor axons. Nevertheless, the fail-
ure of anti-inflammatory and anti-immune therapies
in clinical trials [69] highlights the incomplete know-
ledge of the inappropriate knowledge of the dynamic
(See figure on previous page.)
Fig. 6 The C57SOD1G93A mice have greater macrophagic activity than the 129SvSOD1G93A in the sciatic nerve at disease onset. a–c Confocal
micrographs show higher levels of CCL2 (green) in the sciatic nerve of C57SOD1G93A than 129SvSOD1G93A at disease onset and co-localization
with the axonal marker Smi31 (red); scale bars, 50 μm. d Confocal micrographs showing the co-localization of the signal between CCL2 (green)
and S100β (red) in the sciatic nerve of C57SOD1G93A mice at disease onset; nuclei were stained with Dapi (blue); scale bar, 20 μm. e Representative
western blot images of Iba1 and C3 on sciatic nerve extracts from the C57SOD1G93A, 129SvSOD1G93A mice, and Ntg littermates at disease onset.
Densitometric analysis indicates a correlation between the levels of activation of f C3 and the marked upregulation of g Iba1 expression in the
C57SOD1G93A mice. The graph represents the mean ± SEM (n = 4 mice per group). ****P value <0.0001; **P value <0.01 (C57G93A vs
129SvG93A); °°°°P value <0.0001; °°°P value <0.005 (C57G93A vs 129SvNtg and or C57Ntg); §§P value <0.01 (129SvG93A vs Ntg 129SvNtg and
C57Ntg); ####P value <0.0001 (C57Ntg vs 129SvNtg and 129SvG93A) by two-way ANOVA with Tukey’s post-analysis. h Confocal micrographs
showing higher levels of Iba1 (green) in the sciatic nerve of C57SOD1G93A at disease onset; scale bar, 50 μm. i, j Confocal micrographs of longitudinal
section of sciatic nerve of the C57SOD1G93A mice showing the clear co-localization of signals between S100beta (red) and Iba1 (green); nuclei were
stained with Dapi (blue); scale bars, (i) 20 μm; (j) 10 μm. k Confocal micrographs of longitudinal section of sciatic nerve of the C57SOD1 G93A
mice showing the presence of Iba+ (green) S100β− (red) cells; nuclei were stained with Dapi (blue); scale bar, 10 μm
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immunological changes that occur during the disease
progression and indirectly supports a reconsideration
of the immune system in ALS.
The SOD1G93A mouse used in this study is repre-
sentative of a low percentage of ALS patients [1].
However, so far it is the only model that well recapit-
ulates the clinical and pathological characteristics of
the human disease [1]. For this reason, we expect that
a better understanding of the molecular mechanisms
of cross-talk between damaged axon signaling and the
immune response in SOD1G93A mice should help in
finding new approaches for promoting axonal regen-
eration and muscle reinnervation in ALS. In parallel,
the discovery of genetic factors that may be important
for slowing disease progression could allow identifica-
tion of molecular signatures as potential druggable
targets and disease biomarkers for homogeneous sub-
sets of ALS patients.
Additional file
Additional file 1: Figure S1. Normalized frequency histograms of the α
values computed from all the acquired RP-CARS z-stacks in the four
conditions: Ntg vs. SOD1G93A and C57 vs. 129Sv. Figure S2. GFAP and
P-ERK expression is reduced in the sciatic nerve of 129Sv_Ntg. Figure S3.
H2-K_D (MhcI; red), and β2m (blue) mRNA levels from laser captured
Fig. 7 Immune cell infiltration in the PNS of transgenic ALS mice promotes Schwann cells (SCs) proliferation and axonal maintenance. Schematic
representation of the PNS of C57SOD1G93A mice and 129SvSOD1G93A mice during disease progression. a In the C57SOD1 G93A mice, the activation
of MHCI, autophagocytic SCs, and C3 byproducts leads to the recruitment and interaction of CD8+ T cells and macrophages at the site of injury.
CD8+ T cells and macrophage coordinated activity potentiates the rate of degradation of defective SCs (and myelin debris) in order to stimulate
the de-differentiation and proliferation of SCs and, finally, the remyelination of motor axons and NMJs. b In the 129SvSOD1G93A mice, the lower
phagocytic activity of SCs/macrophage and the lack of CD8+ T cell infiltration result in less removal of defective SCs in addition to reduced SCs
de-differentiation/proliferation which lead to earlier muscle denervation
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MNs of C57Ntg versus 129SvNtg mice. H2-K_D (red), Lmp7 (green) and
β2m (blue) and Tap1 (black) longitudinal mRNA levels from laser
captured MNs of C57SOD1G93A versus Ntg littermates during the
progression of the disease. MHCI immunohistochemistry shows an
increased and widely diffuse expression in the ventral grey and white
matter of the lumbar spinal cord of C57SOD1G93A mice at disease onset
compared to Ntg littermates β2M (green) and LMP7 (red) colocalization
in a subset of lumbar spinal MNs (blue, NT) of C57SOD1G93A mice (inset)
at the onset compared to Ntg littermates (scale bar: 50 μm; inset scale
bar: 20 μm). Representative western blot of LMP7 and β2M expression in
protein extracts from longitudinally dissected lumbar ventral spinal cord
of C57SOD1G93A mice at the disease onset versus Ntg littermates.
Figure S4. β2M is activated in the peripheral nerves of SOD1G93A mice.
Figure S5. Real-time PCR for CD8+ co-receptor transcript in the spinal
cord of 129SvSOD1G93A mice and Ntg littermates at disease onset.
Figure S6. Confocal Z-stack orthogonal projection of a longitudinal section
of sciatic nerve of C57SOD1G93A mice showing the co-localization of
signals between S100beta (red) and Iba1(green), dapi (blue). RT-qPCR for
Ym1, Tnfα, Il6 and Ly6c co-receptor transcript in the sciatic nerve of
C57SOD1G93A mice compared to Ntg littermates at disease onset.
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